A. Nattermann & Cie Gmbh

Nattermann & Cie Gmbh

A. Natternabb & Cie Gmbh

Erich Graf

Sigurd Leyck

Jurgen Biedermann

Hans Betzing

Gerrit Prop

Gerd Hilboll

Albrecht Wendel

Norbert Dereu

Harald O Borbe

Helmut Sies

Michel Evers

Eugen Etschenberg

Hans-Heiner Lautenschlager

Andre Welter

Michael J Parnham

Ille-Stephanie Doppelfeld

Axel Romer

Hartmut Fischer

Rolf Terlinden

Joachim Uhlendorf

Hamied Gabbar

Meinhard Zenk

Benzylselenobenzamides of formula I ##STR1## with inflammation-inhibiting characteristics and used in pharmaceutical preparations.

Antiinflammatory benzylselenobenzamides from aminopyridines and

The invention relates to a new process for the treatment of hypertension and thromboembolic diseases in humans by simultaneous administration of (.+-.)- or (-)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene hydrochloride on the one side, and 4,5-dihydro-6-[4-(1-imidazolyl)-phenyl]-5-methyl-3(2H)-pyridazinone or 4,5-dihydro-6-[4-(1-imidazolyl)-thien-2-yl]-5-methyl-3(2H)-pyridazinone, on the other side, as the active substances.

Process for reducing reflex tachycardia in the treatment of hypertension

The present invention is related to new S-(Carbamoyl-phenylselenyl) derivatives of mercaptanes of the general formula (I) ##STR1## and to a process for the treatment of diseases caused by cell injury due to the increased formation of active oxygen metabolites.

S-[2-phenyl (alkyl) carbamoyl]-phenylselenylmercapto derivatives

The present invention relates to new S-(carbamoylphenylselenyl) derivatives of glutathione and of .alpha.-aminomercaptocarboxylic acids of the general formula (I) ##STR1##

S-(carbamoyl-phenylselenyl) derivatives of glutathione and of

The invention relates to new O-acyl-alkanediol-phospholipids of the general formula I ##STR1## processes for their preparation and process for the treatment of certain diseases in humans.

O-acyl-alkanediol-phospholipids and processes for the treatment of asthma

The present invention is directed to a new process for the treatment of inflammatory diseases and disorders in humans by administering a pharmaceutical preparation containing rosmarinic acid.

Use of rosmarinic acid in the treatment of inflammations and

(3-Alkylamino-2-hydroxypropoxy)-furan-2-carboxylic acid anilides of the formula: ##STR1## in which R.sub.1 denotes a straight or branched C.sub.1 to C.sub.5 alkyl group or a cyclopropyl or cyclopentyl group, R.sub.2 denotes a hydrogen or halogen atom or a methyl, methoxy, nitro or acetyl group, R.sub.3 denotes a hydrogen or halogen atom or a nitro group and A denotes a single bond or the --CH.sub.2 -- or --CH.dbd.CH-- group, and physiologically tolerated acid addition salts thereof possess .beta.-adrenolytic properties and a low toxicity.

(3-Alkylamino-2-hydroxypropoxy)-furan-2-carboxylic acid anilides and

Growing community of inventors

Kerpen-Horrem, Germany

Erich Graf